undamentalytics Newsletter
Sign in

Gevo, Inc. (GEVO) stock

Add to watchlist

Add holding +

NASDAQ: GEVO Nasdaq Specialty Chemicals Next results ~November 10, 2026

D Fundamentals grade

Gevo, Inc. is a US-listed company in the specialty chemicals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$1.3

Forward price-to-sales vs peers

Base case. Range ~$1.0–$2.3. Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative.

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Gevo, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders2 buying, 10 selling2 purchases and 34 sales by directors and officers, last 12 monthsInsider trades
  • Funds74 adding, 67 cuttingOf 25 active managers that changed their stake, 9 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Gevo files

Where Gevo stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $178m, up 121.4% on a year earlier, slower than the 314.9% growth a quarter earlier. That growth ranks 1 of 30 among the specialty chemicals companies we cover. Free-cash-flow margin rose to -31.9% from -114.6% a year earlier. Operating margin narrowed to -102.8% from -72.3%. The diluted share count is up 2.8% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades E. It passes 1 of our 7 financial-health checks. Our price-to-sales vs peers value is $0.91 a share, against a share price of $1.22.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 10, 2026 (estimated)

Gevo, Inc.'s trailing-twelve-month revenue grew 121.4% year on year, with a free-cash-flow margin of -31.9%. Where it stands out: revenue growth of 121.4% ranks 2 of 42 specialty chemicals companies we cover. Where it lags: change in growth rate of -193.6pp ranks 42 of 42 specialty chemicals companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 38.3% while net income fell 264.9%: a 303pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 121.4% over the last 12 months, against a median of 6.0% for specialty chemicals companies we cover.

Things to watch

  • Results due soon. Results are expected around 9 November; the share price can move sharply on the day.
  • Growth slowing. The growth rate is 193.6 points lower than a quarter earlier.
  • Loss-making. Operating margin is -102.8%: costs exceed revenue.
  • Margins narrowing. Operating margin is down 30.5 points on a year ago.
  • Burning cash. Free cash flow was -31.9% of revenue over the last 12 months.
  • Share dilution. Diluted shares rose 2.8% in a year.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
-$0.75 against an average estimate of -$0.02: missed by 3665.1%
Revenue
$47m, up 7.1% on a year earlier
Share reaction
+2.6% in the first session after the results on August 6, 2026, against +0.5% for the S&P 500
Guidance given
non-GAAP Adjusted EBITDA $60m (full year 2026); section 45Z Clean Fuel Production Tax Credit monetization $70m (during 2026)
Next report
November 10, 2026; average EPS estimate $0.05

Gevo's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-6.4%
  • 1 week+2.6%
  • 1 month-10.7%
  • This year-41.5%
  • 1 year-50.0%
  • 5 years-84.4%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$178M
Operating margin
-102.8%
Net margin
-119.9%
EPS (TTM, diluted)
$-0.90

Growth

Revenue growth
+121.4%
Change in growth rate
−193.6 pts
Share count change
+2.8%

Cash

Free cash flow (TTM)
-$56.7M
FCF margin
-31.9%
Stock pay % of revenue
5.5%

Earnings

Last results
August 6, 2026
Next results (est.)
November 9, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Leadership
  2. Leadership
  3. Results
  4. Guidance
  5. Leadership
  6. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Gevo, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Gevo, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 9.5%: the 10-year Treasury yield (4.9%) plus a beta of 1.02 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. — Does not apply: the projected cash flows don't support a positive value
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$1.3 ~$1.0–$2.3 Included, half weight
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: revenue and margins don't support a positive value
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$1.3 ~$1.0–$2.3 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Gevo, Inc. with Specialty Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$248.00$68.00$11.80$1.96$2.31$4.25$4.28$1.90$1.16$2.09$2.00$1.17
Market value$696m$52m$10m$10m$28m$242m$838m$421m$277m$484m$468m$275m
+ Net debt (− = net cash)$32m$8m−$12m−$21m−$2m−$77m$26m−$170m−$230m−$121m$92m$117m
Enterprise value$728m$60m−$2m−$12m$26m$165m$864m$251m$47m$363m$560m$392m
Multiples
Price / sales 23.1x1.9x0.3x0.3x1.1x43.7xn/mn/m16.1x28.6x2.9x1.6x
Price / earnings ————————————
Price / free cash flow ————————————
EV / EBITDA ——————————109.6x—

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

10 /100

Weak moat

How hard Gevo's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -19.9% of total assets over 10 years.

  • Pricing power 0 / 20

    Gross margin has been a median -49.0%, moving by 530.9 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -128.5%; its worst year was -9403.0%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 10 years, at a median -128.2% of revenue.

  • Discipline 0 / 20

    The diluted share count rose 3476372.4% over five years; stock-based pay has been a median 11.0% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 10, 2026, after the close. Analysts expect revenue of $54m and EPS of $0.05 (range $0.05 to $0.05) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$0.44 −212% $195m +21%
Next −$0.02 +96% $206m +6%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +220.5% on 90 days ago. In the last 30 days, 0 analysts raised Gevo, Inc.'s forecast and 0 cut it.

Consensus EPS forecast Gevo, Inc., last 90 days
−$0.60 −$0.40 −$0.20 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.14 Current fiscal year, 60 days ago: −$0.44 Current fiscal year, 30 days ago: −$0.44 Current fiscal year, 7 days ago: −$0.44 Current fiscal year, Now: −$0.44 −$0.44 Next fiscal year, 90 days ago: −$0.08 Next fiscal year, 60 days ago: −$0.02 Next fiscal year, 30 days ago: −$0.02 Next fiscal year, 7 days ago: −$0.02 Next fiscal year, Now: −$0.02 −$0.02

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.14−$0.08
60 days ago −$0.44−$0.02
30 days ago −$0.44−$0.02
7 days ago −$0.44−$0.02
Now −$0.44−$0.02

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.02 −$0.75 −3665.1%
Mar 2026 −$0.02 −$0.09 −285.8%
Dec 2025 −$0.03 −$0.02 +33.3%
Sept 2025 −$0.06 −$0.03 +52.6%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 6, 2026
  • non-GAAP Adjusted EBITDA full year 2026 about $60m Non-GAAP Raised
    “Gevo now expects full year 2026 non-GAAP Adjusted EBITDA 1 to be greater than $60 million, which is more than double the prior target of $30 million.” source
  • Section 45Z Clean Fuel Production Tax Credit monetization during 2026 about $70m
    “Gevo is targeting monetization of more than $70 million in Section 45Z tax credits during 2026 compared to $52 million last year, as a result of continued low-carbon ethanol and renewable natural gas (RNG) production and improvements in the carbon intensity of those products.” source
  • Debottlenecking-driven increase in low-carbon ethanol, coproduct, carbon capture and incentive volumes · Gevo North Dakota starting in 2027 10% to 15%
    “Site improvement efforts at Gevo North Dakota remain on track, with debottlenecking activities expected to deliver increased low-carbon ethanol, coproduct, carbon capture and associated incentive volumes by approximately 10-15%, including 75 million gallons per year of low-carbon ethanol, starting in 2027.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

4 analysts, Oct 2026
Buy250%
Hold250%
Sell00%

Monthly trend

  1. Oct 2026224
  2. Sep 2026224
  3. Aug 2026224
  4. Jul 2026224

Counts of recommendations published by analysts covering Gevo, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
9.8%
of tradable shares
Days to cover
7.34
at average volume
Short interest, 1 month
−3%
to October 15, 2026
Held by institutions
38%
of shares
Held by insiders
4.5%
of shares
Employees
151
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −50.0%

$2.34 on October 31, 2025 to $1.17

ThenNowEffect
Revenue (last 12 months) $80m $178m +121.4%
P/S multiple 6.7x 1.6x −76.8%
Share count 229m 235m −2.7%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −7.9%

$1.27 on November 3, 2023 to $1.17

ThenNowEffect
Revenue (last 12 months) $9m $178m +1839.5%
P/S multiple 32.9x 1.6x −95.3%
Share count 237m 235m +0.9%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
GEVO+1%−56%−39%+80%−4%−42%
Industry peers (median)+19%−25%−8%+6%−15%+6%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
GEVO50%42%50%50%42%18%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
GEVO−71%−67%−54%−58%−64%−60%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 100% from November 2, 2015 to July 1, 2020. Getting back needed a 167400% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$1.11 – $2.78
From 52-week high
−57.9%
vs 50-day average
−16.6%
vs 200-day average
−31.7%
Volatility (1 year)
62%
Beta vs S&P 500
0.85

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
4 up, 8 down
typical move ±10.9%
After a week
6 up, 6 down
typical move ±16.4%
After a month
6 up, 6 down
typical move ±13.2%
Results releasedNext dayS&P 500 next day5 days21 days
August 6, 2026 +2.6% +0.5% +5.9% +7.2%
May 7, 2026 −10.7% +0.5% −18.0% −22.9%
March 5, 2026 +12.0% −1.9% +27.2% +13.6%
November 10, 2025 −4.6% +1.8% −12.8% +2.7%
August 11, 2025 +68.6% +0.9% +42.4% +37.3%
May 13, 2025 −3.4% +0.8% −5.0% +3.4%
March 27, 2025 −7.3% −2.3% −14.6% −3.3%
November 7, 2024 −7.6% +1.2% −13.4% −12.8%
August 8, 2024 +5.9% +2.8% +29.4% +39.2%
May 2, 2024 −4.3% +2.2% +10.1% −5.8%
March 7, 2024 −1.2% +0.4% −17.5% −3.7%
January 24, 2024 −2.2% +0.7% +1.1% −6.5%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Gevo, Inc. in five measures

Fundamentals grade D
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Gevo, Inc.
$0 $50M $100M $150M $200M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $13.4M Revenue (TTM), FY23 Q4: $17.2M Revenue (TTM), FY24 Q1: $17.1M Revenue (TTM), FY24 Q2: $18.2M Revenue (TTM), FY24 Q3: $15.6M Revenue (TTM), FY24 Q4: $16.9M Revenue (TTM), FY25 Q1: $42M Revenue (TTM), FY25 Q2: $80.2M Revenue (TTM), FY25 Q3: $120.9M Revenue (TTM), FY25 Q4: $160.6M Revenue (TTM), FY26 Q1: $174.4M Revenue (TTM), FY26 Q2: $177.5M $177.5M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $13.4M
FY23 Q4 $17.2M
FY24 Q1 $17.1M
FY24 Q2 $18.2M
FY24 Q3 $15.6M
FY24 Q4 $16.9M
FY25 Q1 $42M
FY25 Q2 $80.2M
FY25 Q3 $120.9M
FY25 Q4 $160.6M
FY26 Q1 $174.4M
FY26 Q2 $177.5M
Revenue growth, TTM YoY Gevo, Inc.
-500% 0% 500% 1000% 1500% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 1451.2% Revenue growth, TTM YoY, FY23 Q4: 1363.8% Revenue growth, TTM YoY, FY24 Q1: 242.4% Revenue growth, TTM YoY, FY24 Q2: 98.3% Revenue growth, TTM YoY, FY24 Q3: 16.6% Revenue growth, TTM YoY, FY24 Q4: -1.7% Revenue growth, TTM YoY, FY25 Q1: 145.4% Revenue growth, TTM YoY, FY25 Q2: 341.8% Revenue growth, TTM YoY, FY25 Q3: 675.8% Revenue growth, TTM YoY, FY25 Q4: 849.3% Revenue growth, TTM YoY, FY26 Q1: 314.9% Revenue growth, TTM YoY, FY26 Q2: 121.4% 121.4%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 1451.2%
FY23 Q4 1363.8%
FY24 Q1 242.4%
FY24 Q2 98.3%
FY24 Q3 16.6%
FY24 Q4 -1.7%
FY25 Q1 145.4%
FY25 Q2 341.8%
FY25 Q3 675.8%
FY25 Q4 849.3%
FY26 Q1 314.9%
FY26 Q2 121.4%
Operating margin (TTM) Gevo, Inc.
-800% -600% -400% -200% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -652.1% Operating margin (TTM), FY23 Q4: -475.8% Operating margin (TTM), FY24 Q1: -491.1% Operating margin (TTM), FY24 Q2: -491.6% Operating margin (TTM), FY24 Q3: -593.5% Operating margin (TTM), FY24 Q4: -536.9% Operating margin (TTM), FY25 Q1: -208.9% Operating margin (TTM), FY25 Q2: -72.3% Operating margin (TTM), FY25 Q3: -31.2% Operating margin (TTM), FY25 Q4: -12.6% Operating margin (TTM), FY26 Q1: -2.9% Operating margin (TTM), FY26 Q2: -102.8% -102.8%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -652.1%
FY23 Q4 -475.8%
FY24 Q1 -491.1%
FY24 Q2 -491.6%
FY24 Q3 -593.5%
FY24 Q4 -536.9%
FY25 Q1 -208.9%
FY25 Q2 -72.3%
FY25 Q3 -31.2%
FY25 Q4 -12.6%
FY26 Q1 -2.9%
FY26 Q2 -102.8%
FCF margin (TTM) Gevo, Inc.
-800% -600% -400% -200% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -757.7% FCF margin (TTM), FY23 Q4: -628.9% FCF margin (TTM), FY24 Q1: -647.4% FCF margin (TTM), FY24 Q2: -572.4% FCF margin (TTM), FY24 Q3: -645.5% FCF margin (TTM), FY24 Q4: -641.3% FCF margin (TTM), FY25 Q1: -249.2% FCF margin (TTM), FY25 Q2: -114.6% FCF margin (TTM), FY25 Q3: -70.9% FCF margin (TTM), FY25 Q4: -27.1% FCF margin (TTM), FY26 Q1: -25.0% FCF margin (TTM), FY26 Q2: -31.9% -31.9%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -757.7%
FY23 Q4 -628.9%
FY24 Q1 -647.4%
FY24 Q2 -572.4%
FY24 Q3 -645.5%
FY24 Q4 -641.3%
FY25 Q1 -249.2%
FY25 Q2 -114.6%
FY25 Q3 -70.9%
FY25 Q4 -27.1%
FY26 Q1 -25.0%
FY26 Q2 -31.9%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 1 16 65 24 8 28 30 27 28 33 24 6 1 1 17 17 161 178
Gross profit 1 3 4 −8 −10 −7 −9 −10 −11 −9 −12 −9 −11 — — — — —
EBITDA — −32 −40 −68 −52 −35 −25 −17 −17 −16 −20 −21 −55 −95 −63 −73 5 −156
Operating income — −36 −45 −71 −56 −40 −32 −24 −23 −22 −26 −27 −60 −103 −82 −91 −20 −182
Net income −20 −40 −48 −61 −67 −41 −36 −37 −25 −28 −29 −40 −59 −98 −66 −79 −34 −213
Diluted EPS −$0.23 −$140.40 −$161.25 −$0.47 −$111.15 −$38.34 −$12.90 −$48.38 −$30.23 −$5.74 −$2.35 −$0.71 −$0.30 −$0.44 −$0.28 −$0.34 −$0.14 −$0.90
Growth (year on year)
Revenue — +>999% +293.7% −62.2% −66.3% +243.7% +6.6% −9.7% +1.2% +19.3% −25.5% −77.4% −87.2% +65.3% +>999% −1.7% +849.3% +121.4%
Margins
Gross margin 100.0% 18.0% 6.1% −32.9% −117.8% −25.9% −28.6% −36.0% −38.6% −26.5% −50.0% −171.0% <−999% — — — — —
EBITDA margin — −197.2% −62.1% −279.4% −633.8% −123.5% −84.1% −63.3% −60.4% −47.7% −80.4% −380.4% <−999% <−999% −365.3% −428.8% 3.2% −88.1%
Operating margin — −216.6% −69.2% −293.0% −675.0% −140.7% −105.9% −88.1% −84.6% −67.6% −107.6% −487.0% <−999% <−999% −475.8% −536.9% −12.6% −102.8%
Net margin <−999% −244.6% −74.7% −249.0% −812.3% −145.6% −120.1% −136.8% −89.4% −85.1% −117.0% −725.9% <−999% <−999% −385.0% −464.9% −21.1% −119.9%
Free-cash-flow margin <−999% −132.4% −64.5% −494.1% −691.3% −155.3% −98.3% −97.2% −81.8% −55.0% −111.6% −461.6% <−999% <−999% −628.9% −641.3% −27.1% −31.9%
Cash flow
Cash from operations −16 −21 −34 −68 −47 −39 −28 −21 −21 −16 −21 −19 −48 −44 −54 −57 −13 −16
Capital spending 3 1 8 52 10 5 1 6 2 2 6 6 57 84 54 51 30 40
Free cash flow −19 −22 −42 −120 −57 −44 −30 −26 −23 −18 −27 −26 −105 −128 −108 −108 −44 −57
Stock-based pay 1 11 7 8 4 3 3 1 0 1 1 2 10 17 17 15 9 10
Free cash flow after stock pay −20 −32 −48 −128 −61 −47 −32 −27 −23 −19 −29 −28 −115 −146 −125 −123 −53 −66
Balance sheet
Cash 21 15 94 67 25 6 17 28 12 34 16 78 41 237 298 189 81 58
Total debt 0 19 — 45 38 14 49 36 — 13 14 1 67 68 68 68 173 175
Net debt (negative = net cash) −21 3 −94 −22 13 7 32 8 −12 −21 −2 −77 26 −170 −230 −121 92 117
Diluted shares — — — — — 1m 3m — — 5m 12m 57m 196m 222m 239m 232m 234m 235m
Returned to shareholders
Buybacks — — — — — — — — — — — — — — — 5 — —
Total returned — — — — — — — — — — — — — — — 5 — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 7 checks passed · June 30, 2026
What it owns · $491m
Short-term assets $102mLonger-term assets $389m
What it owes, and who funded it · $483m
Short-term liabilities $38mLonger-term liabilities $172mShareholders' equity $273m
  • Short-term assets cover short-term liabilities $102m of assets due within a year against $38m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $102m short-term assets against $172m of longer-dated liabilities.
  • More cash than debt $58m of cash against $167m of debt.
  • Debt below 40% of shareholders' equity Debt is 61% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 12% to 61% over five years.
  • A year's operating cash flow covers at least 20% of debt −$16m of operating cash flow against $167m of debt.
  • Operating profit covers interest at least five times over Operating income of −$182m against $21m of interest.

From Gevo, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+2.8%
year over year
R&D spending
2.5%
of revenue
Days sales outstanding
25 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in specialty chemicals
Last 12 months unless stated GEVO NL AMTX ARQ FTK NTIC Median
Revenue, last 12 months $178m $162m $220m $123m $293m $92m $906m
Revenue growth, last 12 months 121.4% 6.0% −1.7% 4.9% 36.8% 7.7% 5.4%
Revenue growth, 3-year average 168.7% 0.3% 5.8% 9.9% 15.0% 5.0% 0.9%
Revenue growth, latest quarter 7.1% 8.0% 20.0% 4.5% 70.3% 12.6% 8.3%
Gross margin <−999% 32.1% 10.9% 28.8% 24.7% 35.8% 28.8%
Operating margin −102.8% 9.2% −5.3% −43.0% 12.8% 3.0% 4.3%
Operating margin, 3-year average −222.2% 14.4% −13.1% −15.2% 8.4% 5.8% 5.5%
Net margin −119.9% −15.8% −27.4% −42.6% 13.0% −1.3% 0.8%
Cash from operations / revenue −9.2% 6.9% −1.6% −0.1% −0.8% −2.3% 6.9%
Free-cash-flow margin −31.9% 5.0% −17.9% −4.1% −1.6% −3.5% 4.3%
Free-cash-flow margin, 3-year average −239.6% 0.8% −14.3% −30.7% −1.6% 1.9% 5.1%
Stock pay / revenue 5.5% — 2.3% 3.1% 1.1% 1.4% 1.0%
Change in share count 2.8% 0.0% 28.8% 5.8% 17.5% −2.4% 0.1%

Median of all 42 companies we cover in specialty chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

42 specialty chemicals companies
Measure Company Peer median Rank
Revenue growth Growth 121.4% 6.0% 2 of 42
Change in growth rate Growth -193.6pp +1.3pp 42 of 42
Operating margin Profitability -102.8% 3.8% 32 of 39
Net margin Profitability -119.9% 1.7% 35 of 42
Free-cash-flow margin Cash generation -31.9% 4.8% 36 of 42
Stock pay as % of revenue Cash generation 5.5% 1.0% 30 of 36
Long-term debt as % of assets Balance sheet 34.1% 26.8% 28 of 36
Change in share count Balance sheet 2.8% 0.0% 24 of 37
Days sales outstanding Balance sheet 25 days 59 days 3 of 30

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Gevo North Dakota $137M 85.2% —
Renewable Natural Gas $18M 11.2% ▲ 14.2%
Gevo $5.8M 3.6% ▲ 414.3%
Products and services
Line of business Revenue Share YoY
Ethanol $105M 65.5% —
Ethanol Related Products $31.1M 19.4% —
Environmental Attributes $17.7M 11.0% ▲ 17.4%
Hydrocarbon $4.8M 3.0% ▲ 2840.2%
Renewable Natural Gas Commodity $1M 0.7% ▲ 51.8%
Other Revenue Sale of Isooctane and Software Services $696,000 0.4% ▼ 27.1%

From Gevo, Inc.'s 10-K filed March 5, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$138M
Institutions reporting
148
Shares held vs prior quarter
▲ 5.0%
Positions opened / closed
17 / 28

Top buyers and sellers, Q2 2026: 74 institutions bought and 67 sold ; the biggest buyer was State Street Corp (+4.4M shares) and the biggest seller Goldman Sachs Group Inc (−2.4M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $27.5M 18.3M 19.9% ▲ 5.8%
State Street Corp $20.1M 13.4M 14.6% ▲ 48.1%
Vanguard Capital Management LLC $15.4M 10.3M 11.2% ▲ 1.2%
Geode Capital Management, LLC $9.4M 6.3M 6.8% ▲ 6.7%
Invesco Ltd. $8.4M 5.6M 6.1% ▲ 66.5%
Vanguard Portfolio Management LLC $8.2M 5.5M 6.0% ▲ 7.2%
UBS Group AG $5M 3.3M 3.6% ▲ 53.1%
First Bank & Trust $4.6M 3.1M 3.3% 0.0%
Nuveen, LLC $4.2M 2.8M 3.1% ▼ 22.1%
Bank Of America Corp $3.3M 2.2M 2.4% ▲ 0.8%
Northern Trust Corp $2.8M 1.9M 2.1% ▲ 8.1%
Vanguard Fiduciary Trust Co $2.4M 1.6M 1.7% ▲ 3.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Gevo, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $96,375 2 trades by 2 insiders, last 12 months Insider sales History → $2.8M 34 trades by 10 insiders · 80% under pre-set plans
Net ▼ $2.7M net selling
Insider Date Trade Shares Price Value
Gruber Patrick R. Director September 3, 2026 Sell pre-set plan 3,333 $1.70 $5,666
Bloom Paul D CEO September 3, 2026 Sell pre-set plan 1,514 $1.71 $2,589
Bowron Kimberly T Chief of Staff September 3, 2026 Sell pre-set plan 1,221 $1.71 $2,088
Barber James J Director August 21, 2026 Buy 50,000 $1.54 $77,000
Kettner David Michael Chief Legal & Emrg Biz Officer August 21, 2026 Buy 12,500 $1.55 $19,375
Bloom Paul D CEO August 6, 2026 Sell pre-set plan 31,096 $1.55 $48,199
Agiri Oluwagbemileke Yusuf CFO August 6, 2026 Sell pre-set plan 18,223 $1.54 $28,063
Bowron Kimberly T Chief of Staff August 6, 2026 Sell pre-set plan 10,257 $1.55 $15,898
Gruber Patrick R. Director August 6, 2026 Sell pre-set plan 247,642 $1.51 $373,939
Bloom Paul D CEO June 12, 2026 Sell pre-set plan 35,189 $1.43 $50,320
Ryan Christopher Michael President & COO June 12, 2026 Sell pre-set plan 35,196 $1.43 $50,330
Shafer Andrew Chief Mktg Cust & Brnd Officer June 12, 2026 Sell pre-set plan 9,443 $1.43 $13,503

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 4 trades and filings

No trades in Gevo, Inc. disclosed in the last 12 months; 4 earlier trades on record.

  • Chris Jacobs(R-NY 27):Purchase, $1,001 - $15,000, traded December 12, 2022, filed January 20, 2023
  • Chris Jacobs(R-NY 27):Sale (full), $1,001 - $15,000, traded November 8, 2022, filed December 12, 2022
  • Chris Jacobs(R-NY 27):Sale (partial), $1,001 - $15,000, traded July 18, 2022, filed September 9, 2022

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around November 9, 2026 estimated from the company's past filing pattern, not announced

  • August 6, 2026
  • May 7, 2026
  • March 5, 2026
  • November 10, 2025
  • August 11, 2025
  • May 13, 2025

Recent SEC filings

Data status

When each part of this page on Gevo, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Gevo, Inc. in brief

What does Gevo, Inc. do?
Gevo, Inc. is a US-listed company in the specialty chemicals industry. Its financial year ends in December.
What is Gevo, Inc.'s stock ticker?
Gevo, Inc. trades under the ticker GEVO on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Gevo, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Gevo, Inc. reported revenue of $178M, 121.4% higher than a year earlier, according to its SEC filings.
What is Gevo, Inc.'s free cash flow?
Gevo, Inc.'s free-cash-flow margin is -31.9% of revenue over the trailing twelve months, ranking 36 of the 42 specialty chemicals companies we cover.
Who are Gevo, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., State Street Corp and Vanguard Capital Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Gevo, Inc.'s market cap?
On November 2, 2026, Gevo, Inc.'s market capitalisation was about $275M and net debt of $117M. Market figures come from third-party market data and may be delayed.
How much debt does Gevo, Inc. have?
Gevo, Inc.'s debt-to-equity ratio is 61.2%, from its latest balance sheet (12.2% five years earlier). The financial health section below sets out its other solvency checks.
Who are Gevo, Inc.'s competitors?
In our Specialty Chemicals peer group, the companies closest to Gevo, Inc. are NLI Holdings, Inc., Aemetis, Inc, Arq, Inc., Flotek Industries Inc and Northern Technologies International Corp. The side-by-side comparison below sets their revenue, margins and growth against Gevo, Inc.'s.
Are insiders buying or selling Gevo, Inc. stock?
Over the last 12 months, Gevo, Inc.'s directors and officers reported 2 open-market purchases and 34 sales on Form 4. The insider trading page charts every trade.
When is Gevo, Inc.'s next earnings date?
Around November 10, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Gevo, Inc. announces its own schedule.